Zeb Ahmed, CEO of BES - the specialist in design and construction of cGMP compliant pharmaceutical facilities, discusses the growing demand for sustainable built assets, why the trend is escalating and what can be done to enhance sustainability.
Following on from their recent partnership with Israel Biotech Fund (IBF), EPM caught up with Lonza's Pnina Weitz on the importance of early-stage support for emerging companies, and how robust strategies early on can pave a way to commercialisation.
Technology supplier to the life sciences industry Cytiva is opening a new manufacturing facility in Cardiff, Wales as parts of its global expansion plans.
Adrienne Rivlin, Partner, and Jess Sharpe, Associate, at L.E.K. Consulting assess the rise in investment seen within the psychedelics market for mental health.
EPM speaks to technology company Lifebit about its collaboration with pharmaceutical organisation Boehringer to report on infectious disease outbreaks.
EPM speaks to Marcus Michel, CEO of ACG Group’s Engineering Division in Mumbai, India about the biggest industry challenges, his love of technology and the effect Covid-19 has had on business.
EPM speaks to Sophie Walton, group director of Academic Engagement, CPI, to learn about the Northern BioAccelerator Partnership, which was set up to stimulate investment in the North East’s bioscience sector.
.
Complete Contents of a Modern 100 Acre Large Scale API Production and Development Facility nearby Bristol, UK. Now Accepting Offers
https://auctions.maynards.com/auction-020/auctionDetails/4519
Avara Logo
Ipsen Pharmaceuticals and rare disease digital health specialists, Mendelian, has launched a new partnership to utilise Mendelian’s MendelScan software, a Class 1 Medical Device capable of aiding the rapid identification of people with rare diseases.
EPM editor Reece Armstrong sits down with Panna Sharma, CEO of Lantern Pharma to discuss what an Initial Public Offering of $27 million means for the company and where this biopharma is headed next.
